Literature DB >> 18533402

Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers.

Michael Frumovitz1, Charles F Levenback.   

Abstract

Over the past 15 years, lymphatic mapping and sentinel lymph node biopsy in vulvar, vaginal, and cervical cancers have been explored by gynecologic oncologists around the world. Based on the results of multiple single-institution studies, most in our field are optimistic that these techniques will increase the rates of detection of lymph node metastasis while decreasing the morbidity associated with lymphadenectomy. Large validation studies are currently underway in both the United States and Europe. In this review article, we present the published data on mapping techniques and discuss future considerations for these technologies.

Entities:  

Mesh:

Year:  2008        PMID: 18533402

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  4 in total

1.  Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.

Authors:  Gloria Salvo; Pedro T Ramirez; Charles F Levenback; Mark F Munsell; Elizabeth D Euscher; Pamela T Soliman; Michael Frumovitz
Journal:  Gynecol Oncol       Date:  2017-02-08       Impact factor: 5.482

Review 2.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

Review 3.  Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.

Authors:  Cara Stabile; Abigail Gunn; Yukio Sonoda; Jeanne Carter
Journal:  Transl Androl Urol       Date:  2015-04

4.  Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT.

Authors:  Giorgia Garganese; Luca Tagliaferri; Simona Maria Fragomeni; Valentina Lancellotta; Giuseppe Colloca; Giacomo Corrado; Stefano Gentileschi; Gabriella Macchia; Enrica Tamburrini; Maria Antonietta Gambacorta; Anna Fagotti; Giovanni Scambia
Journal:  J Cancer Res Clin Oncol       Date:  2020-07-12       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.